Back to Search
Start Over
CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia
- Source :
- PR Newswire. March 31, 2021
- Publication Year :
- 2021
-
Abstract
- - Commercial Preparations Underway to Support Potential Approval and Launch of Pacritinib in the United States in 2021 - SEATTLE, March 31, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.656843623